Rosiglitazone improves spatial memory and decreases insoluble A?(1-42) in APP/PS1 mice.
Citation:
O'Reilly JA, Lynch M, Rosiglitazone improves spatial memory and decreases insoluble A?(1-42) in APP/PS1 mice., Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 7, 1, 2012, 140-4Abstract:
Identifying potential novel treatments for patients with Alzheimer?s disease (AD) is a major challenge and drugs used for other indications, particularly if they have anti-
inflammatory properties, are particularly attractive. The
nuclear receptor peroxisome proliferator-activated receptor-! (PPAR!) is a ligand-activated transcription factor.
Author's Homepage:
http://people.tcd.ie/lynchmaDescription:
PUBLISHED
Author: LYNCH, MARINA ANNETTA
Type of material:
Journal ArticleCollections
Series/Report no:
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology;7;
1;
Availability:
Full text availableKeywords:
Alzheimer?s diseaseMetadata
Show full item recordLicences: